| Primary Device ID | M713FPRP200 |
| NIH Device Record Key | 5baa326c-355a-42e0-866b-0753d2a088f2 |
| Commercial Distribution Status | In Commercial Distribution |
| Brand Name | RICHPLAT ORTHO PRP SYSTEM |
| Version Model Number | FPRP20 |
| Catalog Number | FPRP20 |
| Company DUNS | 428453013 |
| Company Name | FIDIA FARMACEUTICI SPA |
| Device Count | 1 |
| DM Exempt | false |
| Pre-market Exempt | false |
| MRI Safety Status | Labeling does not contain MRI Safety Information |
| Human Cell/Tissue Product | false |
| Device Kit | true |
| Device Combination Product | false |
| Single Use | true |
| Lot Batch | true |
| Serial Number | false |
| Manufacturing Date | false |
| Expiration Date | true |
| Donation Id Number | false |
| Contains Natural Rubber Latex | false |
| Labeled No Natural Rubber Latex | false |
| RX Perscription | true |
| OTC Over-The-Counter | false |
| Phone | 973-577-6202 |
| regulatory@fidiapharma.us | |
| Phone | 973-577-6202 |
| regulatory@fidiapharma.us | |
| Phone | 973-577-6202 |
| regulatory@fidiapharma.us | |
| Phone | 973-577-6202 |
| regulatory@fidiapharma.us | |
| Phone | 973-577-6202 |
| regulatory@fidiapharma.us | |
| Phone | 973-577-6202 |
| regulatory@fidiapharma.us | |
| Phone | 973-577-6202 |
| regulatory@fidiapharma.us | |
| Phone | 973-577-6202 |
| regulatory@fidiapharma.us | |
| Phone | 973-577-6202 |
| regulatory@fidiapharma.us | |
| Phone | 973-577-6202 |
| regulatory@fidiapharma.us | |
| Phone | 973-577-6202 |
| regulatory@fidiapharma.us | |
| Phone | 973-577-6202 |
| regulatory@fidiapharma.us | |
| Phone | 973-577-6202 |
| regulatory@fidiapharma.us | |
| Phone | 973-577-6202 |
| regulatory@fidiapharma.us | |
| Phone | 973-577-6202 |
| regulatory@fidiapharma.us | |
| Phone | 973-577-6202 |
| regulatory@fidiapharma.us |
| Device Issuing Agency | Device ID |
|---|---|
| HIBCC | M713FPRP200 [Primary] |
| HIBCC | M713FPRP201 [Package] Package: [10 Units] In Commercial Distribution |
| ORG | Platelet And Plasma Separator For Bone Graft Handling |
| Steralize Prior To Use | false |
| Device Is Sterile | true |
| Public Version Status | New |
| Device Record Status | Published |
| Public Version Number | 1 |
| Public Version Date | 2021-04-02 |
| Device Publish Date | 2021-03-25 |
| M713891220724200 - Hyalgan® Sodium Hylauronate Pre-filled Syringe - 2mL | 2023-10-24 Hyalgan® Sodium Hylauronate (20mg/2mL) in the 2mL syringe is indicated for the treatment of pain in osteoarthritis (OA) of the |
| M713891220724120 - Hyalgan® Sodium Hyaluronate 2mL Vial | 2023-09-21 Hyalgan® Sodium Hylauronate (20mg/2mL) in the 2mL vial is indicated for the treatment of pain in osteoarthritis (OA) of the kne |
| M713494290030100 - Hyalo4 Care Clear Hydrogel, 30g | 2023-06-22 Clear hydrogel wound dressing, 30g, Professional Sample |
| M713494290100350 - Hyalo4 Care Clear Hydrogel, 100g | 2023-06-22 Clear hydrogel wound dressing, 100g Tube |
| M713494440025080 - Hyalo4 Care Hydrogel, 25g | 2023-06-22 Hydrogel wound dressing, 25g, Professional Sample |
| M713494440100350 - Hyalo4 Care Hydrogel, 100g | 2023-06-22 Hydrogel wound dressing, 100g Tube |
| M713891220496010 - Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe, 1 pack | 2022-10-04 HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and resi |
| M71389122049663SAM1 - Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe | 2022-09-16 HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and resi |